share_log

港股通名单今日调整,信达生物涨超16%

The Hong Kong Stock Connect list was adjusted today, and Cinda Biotech rose more than 16%

富途资讯 ·  Sep 7, 2020 11:59

According to the Shenzhen Stock Exchange, since the constituent stocks of the Hang Seng Composite Large Cap Index, the Medium Cap Index, and the Small Cap Index are adjusted regularly, according to the relevant provisions of the “Shenzhen Stock Exchange Shenzhen-Hong Kong Stock Exchange Business Implementation Measures”, the Hong Kong Stock Connect stock list was adjusted and took effect from September 7.

Many of these bids were raised due to this favorable news.

Jiu Maojiu was included in the Hong Kong Stock Exchange's Hong Kong Stock Connect list, up 4.3% to HK$1,794. The latest market capitalization was HK$26.161 billion.

Hygia Healthcare rose 8.37% to HK$51.15, with a turnover of HK$211 million. Furthermore, Morgan Stanley released a research report saying that Hygia Healthcare's profit forecast for the next two years will be raised by 5% to 7%, and the target price will be raised 58% to HK$52, reaffirming the “increase in holdings” rating.

Cinda Biotech rose 16.31%, and its stock price exceeded HK$60.

BeiGene rose 3.87% to close at HK$147.5.

Editor/Charlie

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment